Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|July 12, 2011
Development of c-MET pathway inhibitorsXiangdong Liu, Robert C Newton, Peggy A Scherle
Trends in Molecular Medicine|December 25, 2009
Developing c-MET pathway inhibitors for cancer therapy: progress and challengesXiangdong Liu, Robert C Newton, Peggy A Scherle
Expert Opinion on Investigational Drugs|June 14, 2008
Targeting the c-MET signaling pathway for cancer therapyXiangdong Liu, Wenqing Yao, Robert C Newton, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 24, 2002
Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4)Micky D Tortorella, Rui-Qin Liu, Timothy Burn, et al.
Arthritis and Rheumatism|January 16, 2003
Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced proteinMichael A Pratta, Peggy A Scherle, Gengjie Yang, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
ADAM proteases, ErbB pathways and cancerBin-Bing S Zhou, Jordan S Fridman, Xiangdong Liu, et al.
Cancer Discovery|November 21, 2020
Clinicogenomic Analysis of <i>FGFR2</i>-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to PemigatinibIan M Silverman, Antoine Hollebecque, Luc Friboulet, et al.
The Journal of Biological Chemistry|August 2, 2003
Aggrecan protects cartilage collagen from proteolytic cleavageMichael A Pratta, Wenqing Yao, Carl Decicco, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2017
First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid MalignanciesGregory L Beatty, Peter J O'Dwyer, Jason Clark, et al.
Pageof 5